SRPT Sarepta Therapeutics Potential Buyout Soon
If you haven`t bought SRPT here:
Then you need to know that there is a Massive catalyst coming!
Sarepta Therapeutics is going to announce Duchenne muscular dystrophy Phase 3 data for its SRP-9001-301 - (EMBARK) by mid November.
This week institutions bought calls worth more than 10Mil that SRPT Sarepta Therapeutics will trade above $135 by November 17.
Some even bought the $210 strike price!
They also have a big partnership with the giant Roche Holding AG (RHHBY).
I think SRPT Sarepta Therapeutics is well positioned for a potential takeover soon!
Looking forward to read your opinion about it.
Then you need to know that there is a Massive catalyst coming!
Sarepta Therapeutics is going to announce Duchenne muscular dystrophy Phase 3 data for its SRP-9001-301 - (EMBARK) by mid November.
This week institutions bought calls worth more than 10Mil that SRPT Sarepta Therapeutics will trade above $135 by November 17.
Some even bought the $210 strike price!
They also have a big partnership with the giant Roche Holding AG (RHHBY).
I think SRPT Sarepta Therapeutics is well positioned for a potential takeover soon!
Looking forward to read your opinion about it.
Private Signals patreon.com/PremiumOptionsSignals
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
RESULTS bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
RESULTS bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
관련 발행물
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.